Podcast Episodes
Back to Search
Active Energy CEO: "Our ambition has become much bigger than one project" in UAE
Episode 14635
Active Energy Group PLC (AIM:AEG, OTCID:AEUSF) CEO Paul Elliott tells Proactive's Stephen Gunnion the company has moved beyond single projects, build…
4 days, 4 hours ago
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial
Episode 14638
Medicus Pharma Chief Medical Officer Dr Faisal Mehmud joined Steve Darling from Proactive to discuss the company's receipt of Investigational New Dru…
4 days, 4 hours ago
American Rare Earths advances NASDAQ strategy as U.S. policy boosts Halleck Creek outlook
Episode 14637
American Rare Earths CEO Mark Wall joined Steve Darling from Proactive to provide an update on the company's NASDAQ listing strategy, confirming the …
4 days, 4 hours ago
M2i Global signs strategic collaboration to advance critical minerals projects in Africa
Episode 14636
M2i Global CEO Alberto Rosende joined Steve Darling from Proactive to discuss the company's signing of a non-binding strategic collaboration agreemen…
4 days, 4 hours ago
Gold's cooling off, but the bull case isn't broken, says The Royal Mint's Stuart O'Reilly
Episode 14627
The Royal Mint private wealth consultant Stuart O'Reilly tells Proactive's Stephen Gunnion that gold's core drivers remain firmly in place even after…
4 days, 4 hours ago
Alkane Resources lifts Storheden gold resource to 212,000oz
Episode 14640
Alkane Resources Ltd (ASX: ALK, OTC: ALKEF) managing director and CEO Nic Earner talked with Proactive about the substantial increase in the Mineral …
4 days, 15 hours ago
Actinogen Medical targets November XanaMIA results highlighting strong June quarter
Episode 14641
Actinogen Medical Ltd managing director and CEO Dr Steven Gourlay talked with Proactive about the company’s June quarter progress, including preparat…
4 days, 15 hours ago
Critical Mineral Resources CEO on latest drill results as company eyes a maiden JORC resource
Episode 14634
Critical Mineral Resources PLC (LSE:CMRS, FRA:98J) CEO Charlie Long tells Proactive's Stephen Gunnion that recent drilling at the Agadir Melloul copp…
1 week ago
EMV Capital: AMR Bio targets FDA meeting to clear path for XF-73 Phase 3 trial
Episode 14625
EMV Capital (AIM:EMVC, FRA:NTK1) CEO Dr Ilian Iliev and AMR Bio chair Nigel Brooksby joined Proactive's Stephen Gunnion to discuss progress on XF-73,…
1 week ago
EMV Capital: ProAxsis eyes COPD market breakthrough with Imperial College London study
Episode 14624
EMV Capital (AIM:EMVC, FRA:NTK1) CEO Dr Ilian Iliev and ProAxsis managing director Dr Louise Ryan Murphy joined Proactive's Stephen Gunnion to discus…
1 week ago